0001654954-18-006742.txt : 20180618
0001654954-18-006742.hdr.sgml : 20180618
20180618163026
ACCESSION NUMBER: 0001654954-18-006742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180618
DATE AS OF CHANGE: 20180618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KENNEDY WILLIAM JAMES
CENTRAL INDEX KEY: 0001448888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 18904992
MAIL ADDRESS:
STREET 1: C/O XTL BIOPHARMACEUTICALS LTD
STREET 2: 711 EXECUTIVE BLVD., SUITE Q
CITY: VALLEY COTTAGE
STATE: NY
ZIP: 10989
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
section16.xml
FORM-4
X0306
4
2018-06-14
0001001316
TG THERAPEUTICS, INC.
TGTX
0001448888
KENNEDY WILLIAM JAMES
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
true
false
false
false
COMMON STOCK
2018-06-14
4
S
false
25071
13.45
D
60330
D
Includes shares of restricted Common Stock, which vest over various time periods.
/s/ William Kennedy
2018-06-18